Hims & Hers Health, Inc. (NYSE: HIMS)

Sector: Consumer Defensive Industry: Household & Personal Products CIK: 0001773751
Market Cap 7.86 Bn
P/B 13.53
P/E 58.76
P/S 3.56
ROIC (Qtr) 8.98
Div Yield % 0.00
Rev 1y % (Qtr) 49.16
Total Debt (Qtr) 1.12 Bn
Debt/Equity (Qtr) 1.92

About

Hims & Hers Health, Inc., often abbreviated as Hims & Hers, is a trailblazer in the health and wellness industry, dedicated to transforming how customers meet their health needs. Since its inception in 2017, the company has constructed a platform that offers personalized health and wellness solutions through a digital format, combining a technical platform, a distributed provider network, and clinical capabilities. The company's platform hosts a variety of health and wellness products and services, including prescription medications, over-the-counter...

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 345.78M provide 101.05x coverage of short-term debt 3.42M, demonstrating strong liquidity position and minimal refinancing risk.
  • Tangible assets of 1.78B provide exceptional 15.02x coverage of deferred revenue 118.46M, showing strong service capability backing.
  • Operating cash flow of 325.08M provides solid 0.72x coverage of current liabilities 450.79M, showing strong operational health.
  • Long-term investments of 438.34M provide solid 1.11x backing of working capital 394.48M, showing strategic capital allocation.
  • Operating cash flow of 325.08M provides strong 3.07x coverage of inventory 105.99M, indicating efficient inventory management.

Bear case

  • Operating cash flow of 325.08M barely covers its investment activities of (958.49M), with a coverage ratio of -0.34, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Investment activities of (958.49M) provide weak support for R&D spending of 132.09M, which is -7.26x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Cash reserves of 345.78M provide limited coverage of acquisition spending of (121.77M), which is -2.84x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • The company's operating cash flow of 325.08M shows concerning coverage of stock compensation expenses of 125.11M, with a 2.60 ratio indicating potential earnings quality issues.
  • Operating cash flow of 325.08M provides minimal -54.85x coverage of tax expenses of (5.93M), suggesting potential tax planning inefficiencies or unsustainable tax positions.

Peer comparison

Companies in the Household & Personal Products
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 PG PROCTER & GAMBLE Co 344.56 Bn 20.55 4.06 35.95 Bn
2 UL Unilever Plc 162.92 Bn 24.93 2.32 -
3 CL Colgate Palmolive Co 64.98 Bn 22.35 3.23 8.42 Bn
4 EL Estee Lauder Companies Inc 38.59 Bn -41.50 2.67 9.42 Bn
5 KMB Kimberly Clark Corp 33.56 Bn 17.05 1.86 7.30 Bn
6 KVUE Kenvue Inc. 32.45 Bn 22.64 2.16 8.97 Bn
7 CHD Church & Dwight Co Inc /De/ 20.90 Bn 26.71 3.40 2.20 Bn
8 CLX Clorox Co /De/ 12.14 Bn 15.35 1.79 3.08 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 3.48 1.45
EV to Cash from Ops. EV/CFO 23.94 8.11
EV to Debt EV to Debt 6.96 4.77
EV to EBIT EV/EBIT 60.86 14.54
EV to EBITDA EV/EBITDA 46.86 7.35
EV to Free Cash Flow [EV/FCF] EV/FCF 65.12 2.98
EV to Market Cap EV to Market Cap 0.99 -1.59
EV to Revenue EV/Rev 3.52 2.00
Price to Book Value [P/B] P/B 13.53 -7.69
Price to Earnings [P/E] P/E 58.76 16.46
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 9.11
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 12.82
Dividend per Basic Share Div per Share (Qtr) 0.00 0.92
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 11.25
Interest Coverage Int. cover (Qtr) 0.00 2.65
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -454.72 -96.96
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 107.83 2.29
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 -2.46
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 32.13 -142.06
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 181.58 -154.15
EBIT Growth (1y) % EBIT 1y % (Qtr) 147.72 -155.18
EBT Growth (1y) % EBT 1y % (Qtr) 147.72 -206.88
EPS Growth (1y) % EPS 1y % (Qtr) 25.53 -158.13
FCF Growth (1y) % FCF 1y % (Qtr) -20.14 -5.66
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 64.59 -1.42
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.99 0.82
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.19
Cash Ratio Cash Ratio (Qtr) 0.77 0.76
Current Ratio Curr Ratio (Qtr) 1.88 2.31
Debt to Equity Ratio Debt/Equity (Qtr) 1.92 -2.80
Interest Cover Ratio Int Coverage (Qtr) 0.00 2.65
Times Interest Earned Times Interest Earned (Qtr) 0.00 2.65
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 8.10 -32.28
EBIT Margin % EBIT Margin % (Qtr) 5.78 -37.76
EBT Margin % EBT Margin % (Qtr) 5.78 -40.89
Gross Margin % Gross Margin % (Qtr) 75.00 50.05
Net Profit Margin % Net Margin % (Qtr) 6.10 -42.94